• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-90/I20-30
Device Problem Material Puncture/Hole (1504)
Patient Problem Aneurysm (1708)
Event Date 12/05/2023
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.H3 other text : device not provided for the investigation.
 
Event Description
The patient was treated for an abdominal aortic aneurysm (aaa) on (b)(6) 2018.During the procedure, an afx vela suprarenal was positioned just below the renal artery.However, during retrieval of the delivery system tip, the afx vela suprarenal migrated downward, necessitating the addition of another afx vela suprarenal.The procedure concluded successfully without any signs of endoleaks.A type ii endoleak (non-device-related failure) was detected on subsequent follow-up computed tomography (ct) images, although the exact timing of its occurrence is unknown.The patient was closely monitored in response.On (b)(6) 2023, another follow-up ct scan revealed an aneurysm enlargement and a possible endoleak originating from the main body.On (b)(6) 2024, open surgery was performed.The presence of a type iiib endoleak from suture holes, observed on both the front and back sides, and a type ii endoleak were confirmed.The afx2 stent graft was explanted, and vessel replacement was undertaken.The additional surgical procedure was successfully completed, and the patient's post-operative condition remained stable.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix's practice to make at least three good-faith efforts to retrieve a reported adverse event/incident-related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device was properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.A clinical evaluation of the adverse event/incident could not be completed.No medical records or medical imaging relevant to the reported adverse event/incident were received by endologix.The user facility was unable to provide this information.Due to the absence of medical records and medical imaging, device, use, procedure, and/or anatomy relatedness to this adverse event/incident could not be evaluated.The final patient status was reported as stable.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: h6: investigation finding codes - remove code 3233.H6: investigation conclusion codes - remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key18989256
MDR Text Key338738246
Report Number3011063223-2024-00047
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014825
UDI-Public(01)00818009014825(17)181120
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Distributor
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/20/2018
Device Model NumberBEA25-90/I20-30
Device Lot Number1759574-009
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/12/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/31/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0007-2019
Patient Sequence Number1
Treatment
AFX VELA SUPRARENAL 1774624-006; AFX VELA SUPRARENAL 1929924-002
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-